HLA-DRB1 and multiple sclerosis: To do this, we computed EWAS models controlling for the effect of both the HLA-DRB1 risk haplotype and non-MHC SNPs identified in the 2019 International Multiple Sclerosis Genetics Consortium GWAS [2] using a polygenic risk score (PRS).